Decentralized clinical trials (DCTs) allow patients to participate remotely with data captured using advanced equipment instead of visiting sites often. India can contribute significantly to DCTs by developing analytical tools to update clinical teams, training monitors remotely, managing documentation and helplines from India, and customizing roles like data access and quality control reviewers. DCTs have the potential to transform healthcare by improving access to trials, providing more comprehensive patient data to researchers, and opening up new areas for disease prevention and treatment evaluation using large datasets.